Cura Technologies Q4 FY26 Results Preview Earnings Outlook

Tue Mar 17 2026

Cura Technologies Q4 FY26 results date is all set to be announced soon and most investors are awaiting it. Professionals are expecting an increase in revenue due to higher sales and a significant rise in PAT. Cura Technologies was listed on the National Stock Exchange (NSE) on 21-Mar-2025. Cura Technologies share has its face value of 10 per share, and its NSE symbol is CURAA. The company operates in the Healthcare sector and primarily belongs to the HealthTech industry.

Table of Contents

Cura Technologies Q4 Results 2026 Preview

Cura Technologies Q4 FY26 revenue is expected to be around Strong Growth, representing a 22% YoY increase compared to the same quarter last year.
Profit After Tax, or PAT, is projected to rise 20% YoY.
EBITDA to rise 18%.
Cura Technologies is expected to show Strong Growth in its revenue.

Click and Sign Up to Get Live Updates on Q4 Results

Cura Technologies Share Performance

Over the past six months, Cura Technologies share price has positive by 10% to .
Moreover, over the past year, the stock has NA by NA
Despite this weak short-term performance, Cura Technologies stock has delivered a financially sound NA return over the past 5 years.
As of today, 17-03-2026, the Cura Technologies share price is trading at per share.

Key Factors to Watch for Cura Technologies Q4 Results FY26

Revenue Growth & Segment Performance – Focus on topline growth in the HealthTech industry within the Healthcare sector.
Occupancy Levels & Seat Expansion – Monitor operational expansion and capacity utilisation trends.
Profitability & Margin Trends – Track EBITDA and PAT margins to evaluate cost control and operating efficiency.
Order Book & New Client Wins – Watch for updates on new contracts, partnerships, and long-term deals.
Balance Sheet & Cash Flow Position – Review debt levels, working capital management, and operating cash flows for financial stability.

About Cura Technologies

Cura Technologies operates in healthcare technology solutions focusing on digital health platforms AI integration and expanding service offerings.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Final Thoughts

Cura Technologies is gear up to announce its Q4 FY26 results. Analysts expect 22% revenue growth, a 20% rise in PAT, and a 18% rise in EBITDA. Cura Technologies focuses on revenue growth from order execution, margin improvement, a strong order book, and management.

Stay informed with Univest blogs to get real-time updates on Cura Technologies Q4 results FY26.

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.